These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31451004)

  • 1. Monoclonal Gammopathy of Uncertain Significance and Transthyretin Cardiac Amyloidosis.
    Devesa-Arbiol A; Aceña-Navarro Á; Pello-Lázaro AM; Orejas Orejas M; Askari E; Merino Á; Lapeña G; Navarro Del Amo F; Ibañez B; Tuñón-Fernández J
    Circ Cardiovasc Imaging; 2019 Sep; 12(9):e009493. PubMed ID: 31451004
    [No Abstract]   [Full Text] [Related]  

  • 2. Coexistent transthyretin amyloid cardiomyopathy and monoclonal gammopathy: Diagnostic challenges and prognostic implications.
    Lee Chuy K; Gomez J; Malhotra S
    J Nucl Cardiol; 2022 Apr; 29(2):519-527. PubMed ID: 32720059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amyloidosis in monoclonal gammapathies. Observations of the authors' own cases].
    Anzani P; Bettini R; Zocchi T; Ghezzi I
    Recenti Prog Med; 1991 Feb; 82(2):72-6. PubMed ID: 2034871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis.
    Simons M; Isner JM
    Am J Cardiol; 1992 Feb; 69(4):425-7. PubMed ID: 1734663
    [No Abstract]   [Full Text] [Related]  

  • 7. [Echocardiographic analysis in cardiac amyloidosis].
    Hurrel C; Deriaz-Chessex S; Waeber G; Jeanrenaud X; Périard D
    Praxis (Bern 1994); 2006 Jun; 95(24):977-81. PubMed ID: 16802507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
    Bravo PE; Dorbala S
    Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
    de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac magnetic resonance imaging in amyloidosis].
    Domínguez A; Garrido N; Maceira A
    Rev Esp Cardiol; 2005 Sep; 58(9):1132-3. PubMed ID: 16185629
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
    González-López E; López-Sainz Á; Garcia-Pavia P
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac amyloidosis].
    Hoyer C; Angermann CE; Knop S; Ertl G; Störk S
    Med Klin (Munich); 2008 Mar; 103(3):153-60. PubMed ID: 18344065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating imaging modalities for diagnosing cardiac amyloidosis.
    Ahluwalia M; Reyentovich A; Donnino R; Phillips LM
    J Nucl Cardiol; 2018 Aug; 25(4):1083-1088. PubMed ID: 29987632
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac amyloidosis CT sign.
    Saba SG; Gannon MP; Majure DT; Rahmani N; Shah AB; Palestro CJ; Shah RD
    Clin Res Cardiol; 2021 Nov; 110(11):1841-1846. PubMed ID: 32661673
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and echocardiographic characteristics for differentiating between transthyretin-related and light-chain cardiac amyloidoses.
    Mori M; An Y; Katayama O; Kitagawa T; Sasaki Y; Onaka T; Yonezawa A; Murata K; Yokota T; Ando K; Imada K
    Ann Hematol; 2015 Nov; 94(11):1885-90. PubMed ID: 26251157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG,kappa monoclonal gammopathy of unknown significance with AL amyloidosis simulating giant cell arteritis.
    Pompilian VM; Tănăseanu Ş; Badea C; Zurac S; Socoliuc C; Badelita S; Botez E; Antohe M
    Rom J Intern Med; 2017 Sep; 55(3):179-182. PubMed ID: 28467313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relation of Ejection Fraction and Global Longitudinal Strain in Amyloidosis: Implications for Differential Diagnosis.
    Pagourelias ED; Duchenne J; Mirea O; Vovas G; Van Cleemput J; Delforge M; Kuznetsova T; Bogaert J; Voigt JU
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1358-1359. PubMed ID: 26897665
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between monoclonal gammopathy and cardiac amyloid type.
    Maleszewski JJ; Murray DL; Dispenzieri A; Grogan M; Pereira NL; Jenkins SM; Judge DP; Caturegli P; Vrana JA; Theis JD; Dogan A; Halushka MK
    Cardiovasc Pathol; 2013; 22(3):189-94. PubMed ID: 23102805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impossible quest to make cardiac amyloidosis diagnosis easy.
    Canepa M; Tini G; Montecucco F
    Eur J Clin Invest; 2021 May; 51(5):e13512. PubMed ID: 33569771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.